1. Home
  2. ACOG vs STIM Comparison

ACOG vs STIM Comparison

Compare ACOG & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$6.34

Market Cap

115.5M

Sector

N/A

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.65

Market Cap

105.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACOG
STIM
Founded
2000
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.5M
105.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ACOG
STIM
Price
$6.34
$1.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$18.00
$7.00
AVG Volume (30 Days)
88.7K
1.3M
Earning Date
11-13-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,427,199.00
$129,873,000.00
Revenue This Year
N/A
$101.67
Revenue Next Year
$132.35
$10.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
78.61
52 Week Low
$3.75
$1.25
52 Week High
$11.54
$5.92

Technical Indicators

Market Signals
Indicator
ACOG
STIM
Relative Strength Index (RSI) 54.02 56.54
Support Level $6.11 $1.34
Resistance Level $6.91 $1.70
Average True Range (ATR) 0.46 0.14
MACD 0.06 0.05
Stochastic Oscillator 67.66 96.59

Price Performance

Historical Comparison
ACOG
STIM

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: